APVO Aptevo Therapeutics Inc.

NASDAQ
$1.89

Aptevo Therapeutics Inc. (APVO) Institutional Ownership

What the institutions did with APVO last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.

Managers compared
9
filed both this quarter and last
Managers holding
9
+1 on the quarter
Buyers
2
1 opened new
Sellers
2
0 sold out entirely
Buyer share
50.0%
of managers who traded it
Breadth
+0.0
net buyers, as a share of those trading

Only 9 managers reported a position this quarter, so the percentages above describe a very small sample.

Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.

Sign in or subscribe

Ownership map

Each block is one manager, sized by shares held and colored by how much they moved the position last quarter. Green added, red cut, grey stood pat.

Cut Unchanged Added Color saturates at ±50%.

Largest holders

Manager Shares % of reported
GSA CAPITAL PARTNERS LLP 21.5K 42.7%
VANGUARD CAPITAL MANAGEMENT LLC 12.7K 25.2%
GEODE CAPITAL MANAGEMENT, LLC 10.8K 21.5%
VANGUARD FIDUCIARY TRUST CO 4.1K 8.2%
UBS Group AG 730 1.4%
OSAIC HOLDINGS, INC. 360 0.7%
SBI Securities Co., Ltd. 109 0.2%
BARCLAYS PLC 31 0.1%
DANSKE BANK A/S 1 0.0%

Largest changes

Manager Action Previous Current Change
UBS Group AG Reduced 3.4K 730 -2.7K
GEODE CAPITAL MANAGEMENT, LLC Reduced 13.3K 10.8K -2.5K
GSA CAPITAL PARTNERS LLP Increased 19.6K 21.5K +1.9K
BARCLAYS PLC New 0 31 +31

13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.